Forschungsprojekte
Ergebnisse pro Seite:
10
2021 - 2027
A Phase 1/2a First-in-human Study to Evaluate the Safety, Tolerability and Efficacy of IMA401, a bispecific T cell engaging receptor molecule (TCER®) in patients with recurrent and/or refractory solid tumors.- Marius Fried,
- Dr. med. Alexander Desuki
2021 - 2027
Pre-Screening for A Phase Ia/Ib first-in-human clinical trial to evaluate the safety, tolerability and Initial anti-tumor activity of IMA401, a bispecific T cell engaging receptor molecule (TCER®), in patients with recurrent and/or refractory solid tumors- Marius Fried,
- Dr. med. Alexander Desuki
2021 - 2024
Physikalisch-chemische Stabilitätsuntersuchung von Zytostatika- Prof. Dr. Irene Krämer,
- Helen Linxweiler
2021 - 2024
Optimierung der Arzneimitteltherapiesicherheit von Parenteralia bei erwachsenen und pädiatrischen Patienten- Prof. Dr. Irene Krämer,
- Lutz Kreysing
2021 - 2029
ALLTogether1 – A Treatment study protocol of the ALLTogether Consortium for children and young adults (1-45 years of age) with newly diagnosed acute lymphoblastic leukaemia (ALL)- Univ.-Prof. Dr. med. Jörg Faber,
- Dr. med. Arthur Wingerter,
- Dr. med. Alexandra Russo
2019 - 2022
Analyse und Optimierung der Kommunikation zur Arzneimitteltherapie in einem Krankenhaus der Maximalversorgung- Prof. Dr. Irene Krämer,
- Prof. Dr. Leszek Wojnowski,
- Ann-Kathrin Engl